Join us at #SPLICING2027 to dig into the mechanisms behind it: from spliceosome biology to translational applications.
📅 11-15 July 2027 |📍Caparica, Portugal
📝 Registration deadline: 1 Dec. 2026
🔗 splicing2027.com
#RNASplicing #DNASplicing #AlternativeSplicing @laqv-requimte.bsky.social
📅 11-15 July 2027 |📍Caparica, Portugal
📝 Registration deadline: 1 Dec. 2026
🔗 splicing2027.com
#RNASplicing #DNASplicing #AlternativeSplicing @laqv-requimte.bsky.social
September 29, 2026 at 12:48 PM
Join us at #SPLICING2027 to dig into the mechanisms behind it: from spliceosome biology to translational applications.
📅 11-15 July 2027 |📍Caparica, Portugal
📝 Registration deadline: 1 Dec. 2026
🔗 splicing2027.com
#RNASplicing #DNASplicing #AlternativeSplicing @laqv-requimte.bsky.social
📅 11-15 July 2027 |📍Caparica, Portugal
📝 Registration deadline: 1 Dec. 2026
🔗 splicing2027.com
#RNASplicing #DNASplicing #AlternativeSplicing @laqv-requimte.bsky.social
#oncology #immunotherapy #AkariTherapeutics #novelPH1payload #targetedcancertherapy #PH1 #antibodydrugconjugates #ADCs #oncogenicmutations #DNAsplicing #neoantigens #missplicedproteins #effluxtransporters #oncogenicdrivers #PH1spliceosomemodulatorpayload
pharmatimes.com/news/akari-t...
pharmatimes.com/news/akari-t...
Akari Therapeutics advances research on novel PH1 payload for targeted cancer therapy - PharmaTimes
Akari Therapeutics has reaffirmed its commitment to advancing research on PH1, a novel spliceosome modulator payload used in its antibody drug conjugates
pharmatimes.com
August 11, 2025 at 9:09 AM